Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Current Assets (2016 - 2025)

Historic Current Assets for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $147.3 million.

  • Cartesian Therapeutics' Current Assets fell 3573.25% to $147.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.3 million, marking a year-over-year decrease of 3573.25%. This contributed to the annual value of $216.6 million for FY2024, which is 13876.16% up from last year.
  • According to the latest figures from Q3 2025, Cartesian Therapeutics' Current Assets is $147.3 million, which was down 3573.25% from $163.4 million recorded in Q2 2025.
  • Cartesian Therapeutics' 5-year Current Assets high stood at $229.1 million for Q3 2024, and its period low was $89.9 million during Q3 2023.
  • For the 5-year period, Cartesian Therapeutics' Current Assets averaged around $150.3 million, with its median value being $148.1 million (2022).
  • As far as peak fluctuations go, Cartesian Therapeutics' Current Assets soared by 17322.94% in 2021, and later tumbled by 4371.83% in 2023.
  • Cartesian Therapeutics' Current Assets (Quarter) stood at $144.4 million in 2021, then increased by 2.56% to $148.1 million in 2022, then crashed by 38.75% to $90.7 million in 2023, then skyrocketed by 138.76% to $216.6 million in 2024, then crashed by 32.02% to $147.3 million in 2025.
  • Its Current Assets was $147.3 million in Q3 2025, compared to $163.4 million in Q2 2025 and $185.1 million in Q1 2025.